Cases & Deals

Misonix acquires Solsys Medical, LLC for $109 million

Clients Misonix, Inc.

Jones Day advised Misonix, Inc. in its acquisition of Solsys Medical, LLC, a privately held regenerative medical company, in an all-stock transaction valued at approximately $109 million. Misonix is currently traded on the NASDAQ Global Market. In the transaction, Misonix and Solsys Medical became subsidiaries of a new publicly traded holding company that is traded on the NASDAQ Global Market. Current shareholders of Misonix now own approximately 64% of the new holding company and current unitholders of Solsys now own approximately 36%. In connection with the transaction, Misonix entered into an amended and restated loan facility, drew additional funds under the facility, and expanded its future borrowing capacity.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.